Search for: "Pfizer, Inc"
Results 81 - 100
of 1,517
Sorted by Relevance
|
Sort by Date
1 Jul 2010, 6:30 am
Senator Charles Grassley asked 16 drugmakers, including Pfizer Inc., AstraZeneca Plc and Eli Lilly & Co., to reveal how they treat whistleblowers who file complaints under the False Claims Act.Grassley, an Iowa Republican, sent letters June 28 that posed eight questions such as how companies notify employees of the law, how they treat whistleblowers and what changes they have made in response to a 2009 law extending anti-retaliation protections. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
1 Feb 2012, 8:04 am
” Tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. [read post]
9 Nov 2016, 11:10 am
In a separate court document, "BRISTOL-MYERS SQUIBB COMPANY AND PFIZER INC. [read post]
12 Dec 2010, 6:59 pm
Pfizer, Inc. says [read post]
29 Jul 2012, 5:56 pm
Pfizer Inc. and Johnson & Johnson had bad news to report last week on one of four clinical trials of their Alzheimer’s disease drug bapineuzumab. [read post]
26 Jun 2013, 6:30 am
Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
9 Nov 2020, 3:03 pm
A vaccine developed by Pfizer Inc. [read post]
24 Jan 2009, 5:37 am
It employs 5,000 in the Phila. region.By Miriam HillInquirer Staff WriterA $60 billion purchase of drugmaker Wyeth by rival Pfizer Inc. is not a certainty, but if it does happen, it could lead to thousands of job cuts throughout Wyeth, including at its extensive Philadelphia-area operations.No one from the two pharmaceutical companies would comment yesterday on reports of ongoing acquisition talks. [read post]
3 Sep 2009, 1:09 pm
Dept. of Justice announced that Pfizer Inc. will pay $2.3 billion in civil False Claims Act damages and criminal fines to resolve allegations that the company illegally promoted a number of its drugs for off-label uses.Six separate whistleblower suits were filed against the company in this matter.The bulk of the settlement, $1.8 billion, is due to the company's off-label marketing of Bextra. [read post]
22 Jan 2007, 10:52 am
The Associated Press just reported an announcement by Pfizer Inc. that it will cut 10,000 jobs in an effort to decrease costs by $2 billion. [read post]
23 Jul 2007, 9:45 am
Here's an excerpt:Nigerian government lawyers withdrew a $7 billion civil lawsuit against Pfizer Inc. on Friday, saying they have discovered new material and... [read post]
2 Apr 2012, 11:22 am
Regardless, the damage is done, and the big question remains: Is Pfizer Inc. vulnerable to hefty damage claims because of this mishap? [read post]
7 May 2020, 11:51 am
Just this week, Pfizer, Inc. announced that it had administered the first round of its experimental coronavirus vaccines on patients in the U.S. [read post]
28 Mar 2008, 12:45 am
Immigration and Customs Enforcement agents arrested Alan Hesketh, patent director of Pfizer Inc., at John F. [read post]
19 May 2015, 12:58 pm
Louis concluded last month the antidepressant Zoloft, manufactured by Pfizer Inc., did not cause birth defects in one case. [read post]
24 Oct 2008, 3:19 pm
Pfizer Inc. said it agreed earlier this week to pay $894 million to settle most Celebrex and Bextra claims. [read post]
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United States, as of Nov.… [read post]
